Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

Presentation THT Abstracts 2025

Evaluating Glucagon-Like Peptide Agonists and Glucose-Dependent Insulinotropic Polypeptide Receptor Agonists Treatment in Heart Failure With Preserved Ejection Fraction: A Meta-Analysis of Global RCTs

February 11, 2025

Presentation THT Abstracts 2025

Healthcare Professionals' Perspectives on the Treatment of Systemic Inflammation With Heart Failure and Associated Patient Journey Mapping

Presenter: Marat Fudim

February 11, 2025

Presentation THT Abstracts 2025

A Real-World Survey-Based Study on the Characteristics and Treatment Patterns of People With Transthyretin Amyloid Polyneuropathy

Presenter: Klas Rikner

February 11, 2025

Presentation THT Abstracts 2025

Clinical Outcomes Among Patients With HFpEF and Peripheral Arterial Disease Undergoing Revascularization

Presenter: Phuuwadith Wattanachayakul

February 11, 2025

Presentation THT Abstracts 2024

Percutaneous VA-ECMO during TAVI in Patients with Cardiogenic Shock and Severely Depressed Left Ventricular Function

Presenter: Eduardo Arias

March 05, 2024

Presentation THT Abstracts 2024

Central and Peripheral Determinants of Exercise with the HeartMate 3TM LVAD

Presenter: David Golombeck

March 05, 2024

Presentation THT Abstracts 2024

Glucagon-Like Peptide-1 Agonist Experience in Patients With Left Ventricular Assist Devices

Presenter: Boaz Elad

March 05, 2024

Presentation THT Abstracts 2024

Non-Invasive Multisensor Algorithm to Predict Worsening Heart Failure by Change in Natriuretic Peptides

Presenter: Andrew Sauer

March 05, 2024

Presentation THT Abstracts 2024

Percutaneous Axillary Intra-aortic Balloon Pumps for Cardiogenic Shock Due to Acute Decompensated Heart Failure as a Bridge to Ambulation and Heart Transplant

Presenter: Justin Cortez

March 05, 2024

Presentation THT Abstracts 2024

Association Between Inpatient Percutaneous Coronary Intervention Volume and Thirty-Day Readmissions After Acute†Myocardial Infarction- Cardiogenic Shock

Presenter: Kannu Bansal

March 04, 2024

Presentation THT Abstracts 2024

First in Man CardiALLO NK1R+ MSC Phase I/II Trial in Ischemic NYHA II and III HFrEF

Presenter: Carl Pepine

March 04, 2024

Presentation THT Abstracts 2024

Early Feasibility Study of the Vivasure PerQsealÆ Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Presenter: Rajiv Tayal

March 04, 2024

Presentation THT Abstracts 2024

Three-Dimensional Morphological Analysis por Percutaneous Closure Candidate Selection and In-Hospital Mortality Prediction in Ischemic Ventricular Septal Ruptures

Presenter: Eduardo Arias

March 04, 2024

Advertisement

Evaluating Glucagon-Like Peptide Agonists and Glucose-Dependent Insulinotropic Polypeptide Receptor Agonists Treatment in Heart Failure With Preserved Ejection Fraction: A Meta-Analysis of Global RCTs

Healthcare Professionals' Perspectives on the Treatment of Systemic Inflammation With Heart Failure and Associated Patient Journey Mapping

A Real-World Survey-Based Study on the Characteristics and Treatment Patterns of People With Transthyretin Amyloid Polyneuropathy

Clinical Outcomes Among Patients With HFpEF and Peripheral Arterial Disease Undergoing Revascularization

Percutaneous VA-ECMO during TAVI in Patients with Cardiogenic Shock and Severely Depressed Left Ventricular Function

Central and Peripheral Determinants of Exercise with the HeartMate 3TM LVAD

Glucagon-Like Peptide-1 Agonist Experience in Patients With Left Ventricular Assist Devices

Non-Invasive Multisensor Algorithm to Predict Worsening Heart Failure by Change in Natriuretic Peptides

Percutaneous Axillary Intra-aortic Balloon Pumps for Cardiogenic Shock Due to Acute Decompensated Heart Failure as a Bridge to Ambulation and Heart Transplant

Association Between Inpatient Percutaneous Coronary Intervention Volume and Thirty-Day Readmissions After Acute†Myocardial Infarction- Cardiogenic Shock

First in Man CardiALLO NK1R+ MSC Phase I/II Trial in Ischemic NYHA II and III HFrEF

Early Feasibility Study of the Vivasure PerQsealÆ Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Three-Dimensional Morphological Analysis por Percutaneous Closure Candidate Selection and In-Hospital Mortality Prediction in Ischemic Ventricular Septal Ruptures

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content